enterobacteriaceae

Conclusions: Carbapenem resistance among common Enterobacteriaceae has increased over the past decade; most CRE are associated with health-care exposures.

Already, we're seeing some pretty scary bugs with CRE (carbapenem-resistant enterobacteriaceae) and XDR-TB (extensively drug-resistant tuberculosis) and others.

Such inflammation can, in turn, deplete the gut microbiota (and consequently microbial gene diversity), and allow facultative anaerobes such as Enterobacteriaceae to proliferate.

The majority of bacteria belonged to the Enterobacteriaceae (42%), followed by Bacillus spp.

Over the past decade, however, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a cause of difficult-to-treat infections associated with high mortality.

They're enterobacteriaceae that are resistant to carbapenems.

They’re members of a notorious family of multidrug-resistant pathogens, called carbapenem-resistant Enterobacteriaceae (CRE), which collectively have mortality rates as high as 50 percent and have spread rapidly around the globe in recent years.

Also remember that CRE are not more virulent than non resistant forms of enterobacteriaceae, and those certainly don't kill 4 in 10 (although that family seems to have all the really bad bacteria like E.

The report abstract, which leads into many more details: "Background: Enterobacteriaceae are a family of bacteria that commonly cause infections in health-care settings as well as in the community.

Extended-spectrum beta-lactamases are a major problem with several emerging infections, mostly Enterobacteriaceae.

Among Enterobacteriaceae, resistance to broad-spectrum carbapenem antimicrobials has been uncommon.

It doesn't seem that hard to imagine unintended consequences if we eradicated not only the plague bacterium (probably Yersinia pestis ), but the entire family Enterobacteriaceae, for example.